Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.270
-0.030 (-0.91%)
At close: Mar 13, 2026, 4:00 PM EDT
3.190
-0.080 (-2.45%)
After-hours: Mar 13, 2026, 7:44 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $198.08 million as of March 13, 2026. Its market cap has increased by 161.66% in one year.
Market Cap
198.08M
Enterprise Value
92.86M
1-Year Change
161.66%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $198.08M, a decrease of -67.97%. That is a compound annual growth rate of -21.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 198.08M | 54.98% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 207.91M |
| Cibus | 199.76M |
| Galectin Therapeutics | 199.22M |
| Sutro Biopharma | 196.49M |
| NeOnc Technologies Holdings | 196.29M |
| Cartesian Therapeutics | 195.90M |
| Zentalis Pharmaceuticals | 195.80M |
| Adagene | 194.65M |